Mechanisms of amyloid nucleation
淀粉样蛋白成核机制
基本信息
- 批准号:8638028
- 负责人:
- 金额:$ 28.79万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-04-01 至 2016-03-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAmidesAmyloidAmyloid FibrilsAmyloidosisApplications GrantsAreaBacterial AdhesinsBiological AssayBiological ProcessBiologyBiotechnologyCell NucleusCellsCellular biologyChargeComplexCrowdingCytoplasmic GranulesDNADNA Sequence RearrangementDataDependenceDiseaseDrug FormulationsElementsEnzymesEquationEquilibriumEventExhibitsGrowthHormonesHydrogen BondingInclusion BodiesIndiumInsulinKineticsLengthLiteratureMammalsMethodsMicrobial BiofilmsModelingMolecularMutationNatureNeurodegenerative DisordersNormal CellOrganismPatternPeptidesPharmacologic SubstancePlayPolymer ChemistryPolymersPositioning AttributePreparationProcessPropertyProtein BiosynthesisProteinsReactionRecombinant ProteinsRecombinantsRoleSeriesSodium ChlorideSolutionsSorting - Cell MovementStagingStressStructural ModelsStructureSystemTemperatureTestingTherapeutic AgentsThermodynamicsTimeUreaVertebral columnWorkamyloid fibril formationamyloid formationamyloid structurebasebiological systemsdesigndisulfide bonddriving forceexpectationfallshuman diseasemonomernormal agingnovel strategiespolyglutaminepolymerizationprotein aggregateprotein aggregationprotein expressionprotein foldingprotein functionprotein structureresearch studysuccess
项目摘要
DESCRIPTION (provided by applicant): The aggregation of peptides and proteins into highly organized aggregates such as amyloid fibrils is a very important and fundamental process in biology. Most proteins suffer some degree of aggregation after they are synthesized in the cell, and a variety of cellular mechanisms have evolved to deal with the consequences of aggregation, which range from rendering protein synthesis inefficient to creating toxic species. In some cases amyloid fibril formation is beneficial and necessary for a particular biological function, such as the bacterial adhesins that support biofilm growth, and the secretory storage granules used by mammals for storage and release of protein hormones like insulin. In many other cases amyloid fibril formation is detrimental, being associated with serious human diseases as well as with normal aging. Protein aggregation also plays important roles in biotechnology, in the recombinant synthesis, purification and formulation of protein therapeutic agents. For all of these reasons it is important to come to a better mechanistic understanding of the protein aggregation process, and in particular the events that initiate aggregation, a process termed nucleation. Many cases of spontaneous amyloid fibril formation involve highly complex nucleation mechanisms with multiple molecular species in high flux, greatly complicating nucleation analysis. In other cases, however, nucleation is more simple, and in fact more resembles the classical model of nucleated growth polymerization from basic polymer chemistry. This grant application proposes a series of experiments to unravel the nucleation mechanism of a series of modified polyglutamine (polyQ) molecules, which are an important place to begin to study nucleation because they fall into the second, more simple class of nucleation mechanisms. The basic approach will be to design polyQ sequences containing various mutations that are predicted to have defined conformational effects on the solution structure of the protein, and to carry out detailed nucleation kinetics analyses on these proteins. These analyses will yield important parameters such as the thermodynamic driving force for nucleus formation, and the thermodynamics associated with simple fibril growth (elongation). These experimentally determined values for the energetics of amyloid nucleation and growth will then be compared with expectations based on the known conformational tendencies introduced into the test polyQ molecules by the added mutations. In this way, certain hypotheses for the structural nature of the aggregation nucleus will be tested. Success in this project will provide important clues as to how amyloid formation is nucleated that should have implications over broad areas of biology, such as biological systems affected by amyloid diseases, as well as related protein aggregation processes that occur in normal cell biology and in normal aging. Since it is likely that conformational rearrangements are important even in the more complex type of amyloid nucleation reactions, the results may open the way to new approaches to the study of the more complex and currently largely impenetrable class of nucleation mechanisms.
描述(由申请人提供):将肽和蛋白质的聚集到高度有组织的聚集体中,例如淀粉样蛋白原纤维是生物学中非常重要且基本的过程。大多数蛋白质在细胞中合成后都会遭受一定程度的聚集,并且各种细胞机制已经进化以应对聚集的后果,从呈现蛋白质合成效率低下到产生有毒物种。在某些情况下,淀粉样蛋白原纤维形成是有益的,对于特定的生物学功能是有益的,也是必要的,例如支持生物膜生长的细菌粘附素,以及哺乳动物用于储存和释放胰岛素等蛋白质激素的分泌储存颗粒。在许多其他情况下,淀粉样蛋白原纤维形成是有害的,与严重的人类疾病以及正常衰老有关。蛋白质聚集在生物技术,在蛋白质治疗剂的重组合成,纯化和制定中也起着重要作用。由于所有这些原因,重要的是要更好地了解蛋白质聚集过程,尤其是启动聚集的事件,这是一种称为成核的过程。许多自发淀粉样蛋白原纤维形成的病例涉及高通量中多个分子物种的高度复杂成核机制,这极大地使成核分析复杂化。然而,在其他情况下,成核更简单,实际上更类似于基本聚合物化学的成核生长聚合的经典模型。该赠款的应用提出了一系列实验,以揭示一系列改良的聚谷氨酰胺(PolyQ)分子的成核机制,它们是开始研究成核的重要场所,因为它们属于第二类,更简单的成核机制。基本方法是设计包含各种突变的PolyQ序列,这些突变被预测对蛋白质的溶液结构定义了构象作用,并对这些蛋白质进行了详细的成核动力学分析。这些分析将产生重要参数,例如核形成的热力学驱动力,以及与简单原纤维生长(延长)相关的热力学。然后,这些实验确定的淀粉样蛋白成核和生长能量的值将与基于添加突变引入测试PolyQ分子中的已知构象趋势的期望进行比较。以这种方式,将测试有关聚集核的结构性的某些假设。该项目的成功将提供有关如何对淀粉样蛋白形成的成核形成的重要线索,这些形成应该对广泛的生物学领域具有影响,例如受淀粉样蛋白疾病影响的生物系统以及在正常细胞生物学和正常生物学中发生的相关蛋白质聚集过程老化。由于即使在更复杂的淀粉样蛋白成核反应类型中,构象重排也很重要,因此结果可能为研究更复杂且目前在很大程度上无法穿透的成核机制的新方法开辟了道路。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RONALD B WETZEL其他文献
RONALD B WETZEL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RONALD B WETZEL', 18)}}的其他基金
Training in the Molecular Biophysics and Structural Biology
分子生物物理学和结构生物学培训
- 批准号:
8076450 - 财政年份:2011
- 资助金额:
$ 28.79万 - 项目类别:
Training in the Molecular Biophysics and Structural Biology
分子生物物理学和结构生物学培训
- 批准号:
8877563 - 财政年份:2011
- 资助金额:
$ 28.79万 - 项目类别:
Training in the Molecular Biophysics and Structural Biology
分子生物物理学和结构生物学培训
- 批准号:
8695410 - 财政年份:2011
- 资助金额:
$ 28.79万 - 项目类别:
Training in the Molecular Biophysics and Structural Biology
分子生物物理学和结构生物学培训
- 批准号:
8501540 - 财政年份:2011
- 资助金额:
$ 28.79万 - 项目类别:
Training in the Molecular Biophysics and Structural Biology
分子生物物理学和结构生物学培训
- 批准号:
8286156 - 财政年份:2011
- 资助金额:
$ 28.79万 - 项目类别:
High throughput assay development for Huntington?s Disease
亨廷顿病的高通量检测开发
- 批准号:
7826695 - 财政年份:2009
- 资助金额:
$ 28.79万 - 项目类别:
Conformational antibodies recognizing amyloid epitopes
识别淀粉样蛋白表位的构象抗体
- 批准号:
7191639 - 财政年份:2003
- 资助金额:
$ 28.79万 - 项目类别:
Conformational antibodies recognizing amyloid epitopes
识别淀粉样蛋白表位的构象抗体
- 批准号:
7058728 - 财政年份:2003
- 资助金额:
$ 28.79万 - 项目类别:
相似国自然基金
HIF-1α调控心脏LYVE1+常驻巨噬细胞谷氨酰胺代谢促进适应性心脏重塑的作用机制研究
- 批准号:82300447
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
中性神经酰胺酶NcDase调控肿瘤相关巨噬细胞脂代谢介导CD8+T细胞抗乳腺癌的机制研究
- 批准号:82372918
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
丙酸通过改善线粒体功能障碍缓解丙烯酰胺诱导神经损伤的分子机制
- 批准号:32302251
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
组蛋白去甲基化酶1调控神经酰胺代谢重编程促进食管鳞癌5-氟尿嘧啶耐药的机制研究
- 批准号:82304560
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
聚酰胺多嵌段共聚物聚合过程相态演变与界面调控机制探索
- 批准号:22308098
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Conformational properties of misfolded protein aggregates in cases involving the co-occurrence of prion disease and Alzehimer's disease or prion disease and CTE
涉及朊病毒病和阿尔茨海默病或朊病毒病和 CTE 同时发生的情况下错误折叠蛋白聚集体的构象特性
- 批准号:
10682584 - 财政年份:2022
- 资助金额:
$ 28.79万 - 项目类别:
Conformational properties of misfolded protein aggregates in cases involving the co-occurrence of prion disease and Alzehimer's disease or prion disease and CTE
朊病毒病和阿尔茨海默病或朊病毒病和 CTE 同时发生的情况下错误折叠蛋白聚集体的构象特性
- 批准号:
10664201 - 财政年份:2022
- 资助金额:
$ 28.79万 - 项目类别:
Conformational properties of misfolded protein aggregates in cases involving the co-occurrence of prion disease and Alzehimer's disease or prion disease and CTE
朊病毒病和阿尔茨海默病或朊病毒病和 CTE 同时发生的情况下错误折叠蛋白聚集体的构象特性
- 批准号:
10264794 - 财政年份:2020
- 资助金额:
$ 28.79万 - 项目类别:
Conformational properties of misfolded protein aggregates in cases involving the co-occurrence of prion disease and Alzehimer's disease or prion disease and CTE
朊病毒病和阿尔茨海默病或朊病毒病和 CTE 同时发生的情况下错误折叠蛋白聚集体的构象特性
- 批准号:
10039820 - 财政年份:2020
- 资助金额:
$ 28.79万 - 项目类别:
Peptoid Antagonists of the ApoE/ABeta Interaction as a Novel Anti-ABeta Therapy.
ApoE/Aβ 相互作用的类肽拮抗剂作为一种新型抗 Aβ 疗法。
- 批准号:
8742110 - 财政年份:2013
- 资助金额:
$ 28.79万 - 项目类别: